Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in: Quality of Life Research 8/2009

Open Access 01-10-2009 | Brief Communication

Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer

Authors: Roderick C. N. van den Bergh, Ida J. Korfage, Gerard J. J. M. Borsboom, Ewout W. Steyerberg, Marie-Louise Essink-Bot

Published in: Quality of Life Research | Issue 8/2009

Login to get access

Abstract

Purpose

Men with prostate cancer (PC) may show specific disease-related anxiety. We evaluated the psychometric properties of the Dutch adaptation of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).

Methods

The MAX-PC was translated using standardized forward–backward procedures. Patients (N = 150) on active surveillance, a strategy of initially withholding active therapy, for recently diagnosed early PC were mailed a questionnaire. Internal consistency was estimated using Cronbach’s alpha. The scale structure was analyzed using confirmatory factor analysis (CFA). Construct validity was evaluated by Pearson’s correlations between MAX-PC scores and scores on decisional conflict (DCS), generic anxiety (STAI), depression (CES-D), and general mental health (SF-12 MCS).

Results

Data from 129 respondents were used (response rate 86%). Cronbach’s alpha for the total score and the three subscales were 0.77, 0.91, 0.64, and 0.85, respectively. CFA largely confirmed the three-factor structure as used in the original publication (model fit: χ2 149, P = 0.051). The patterns of directions and sizes of the correlations (r = 0.36–0.66) between MAX-PC scale scores and the other variables were in accordance with a priori hypotheses, except for the prostate-specific antigen anxiety subscale. The relatively poor performance of this scale in the original version was replicated.

Conclusions

The structure and validity of the MAX-PC to quantify PC-specific anxiety were largely confirmed in Dutch patients.
Literature
1.
Boyle, P., & Ferlay, J. (2005). Cancer incidence and mortality in Europe, 2004. Annals of Oncology, 16(3), 481–488.PubMedCrossRef
2.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., et al. (2008). Cancer statistics, 2008. CA: A Cancer Journal for Clinicians, 58(2), 71–96.CrossRef
3.
Roth, A. J., Rosenfeld, B., Kornblith, A. B., Gibson, C., Scher, H. I., Curley-Smart, T., et al. (2003). The memorial anxiety scale for prostate cancer: Validation of a new scale to measure anxiety in men with prostate cancer. Cancer, 97(11), 2910–2918.PubMedCrossRef
4.
Roth, A., Nelson, C. J., Rosenfeld, B., Warshowski, A., O’Shea, N., Scher, H., et al. (2006). Assessing anxiety in men with prostate cancer: Further data on the reliability and validity of the memorial anxiety scale for prostate cancer (MAX-PC). Psychosomatics, 47(4), 340–347.PubMedCrossRef
5.
Dale, W., Hemmerich, J., & Meltzer, D. (2007). Extending the validity of the memorial anxiety scale for prostate cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology, 16(5), 493–498.PubMedCrossRef
6.
Mehnert, A., Lehmann, C., Schulte, T., & Koch, U. (2007). Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie, 30(11), 551–556.PubMedCrossRef
7.
Guillemin, F., Bombardier, C., & Beaton, D. (1993). Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. Journal of Clinical Epidemiology, 46(12), 1417–1432.PubMedCrossRef
8.
van den Bergh, R. C., Roemeling, S., Roobol, M. J., Roobol, W., Schroder, F. H., & Bangma, C. H. (2007). Prospective validation of active surveillance in prostate cancer: The PRIAS study. European Urology, 52(6), 1560–1563.PubMedCrossRef
9.
O’Connor, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25–30.PubMedCrossRef
10.
Roberts, R. E., & Vernon, S. W. (1983). The center for epidemiologic studies depression scale: Its use in a community sample. American Journal of Psychiatry, 140(1), 41–46.PubMed
11.
Marteau, T. M., & Bekker, H. (1992). The development of a six-item short-form of the state scale of the Spielberger state-trait anxiety inventory (STAI). British Journal of Clinical Psychology, 31(Pt 3), 301–306.PubMed
12.
Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef
13.
Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.PubMedCrossRef
14.
Kathleenl, N. L. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res, 11(3):193–205.CrossRef
15.
Bollen, K. A. (1989). Structural equations with latent variables. New York: Wiley Inc.
16.
Fayers, P. M. (2008). The scales were highly correlated: P = 0.0001. Quality of Life Research, 17(5), 651–652.PubMedCrossRef
17.
Hinkle, D. E., Wiersma, W., & Jurs, S. G. (1998). Applied statistics for the behavioral sciences (5th ed.). Boston: Houghton Mifflin College Div.
18.
Efron, B., & Tibshirani, R. J. (1993). An introduction to the bootstrap. London: Chapman & Hall.
19.
Jöreskog, K., & Sörbom, D. (1996). LISREL 8 user’s reference guide. Chicago: Scientific Software International.
Metadata
Title
Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer
Authors
Roderick C. N. van den Bergh
Ida J. Korfage
Gerard J. J. M. Borsboom
Ewout W. Steyerberg
Marie-Louise Essink-Bot
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
Quality of Life Research / Issue 8/2009
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9516-9

Other articles of this Issue 8/2009

Quality of Life Research 8/2009 Go to the issue

OriginalPaper

Differential item functioning was negligible in an adaptive test of functional status for patients with knee impairments who spoke English or Hebrew

OriginalPaper

How sharp is the short QuickDASH? A refined content and validity analysis of the short form of the disabilities of the shoulder, arm and hand questionnaire in the strata of symptoms and function and specific joint conditions

OriginalPaper

Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease

OriginalPaper

Responsiveness of the Harris Hip Score and the SF-36: five years after total hip arthroplasty

OriginalPaper

The complexity of the relationship between chronic pain and quality of life: a study of the general Norwegian population

OriginalPaper

Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders